Akebia Therapeutics (AKBA) Change in Acquisitions & Divestments (2014 - 2021)

Akebia Therapeutics (AKBA) has 8 years of Change in Acquisitions & Divestments data on file, last reported at $20.0 million in Q2 2021.

• Change in Acquisitions & Divestments for Q2 2021 came in at $20.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was $20.0 million (down 75.0% YoY), and the FY2021 annual result was $40.0 million, down 33.6% from the prior year.
• Change in Acquisitions & Divestments held at $20.0 million in Q2 2021 per AKBA's latest filing, from $20.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $230.3 million in Q4 2018 and troughed at -$109.8 million in Q3 2018.
• A 5-year average of $31.4 million and a median of $27.1 million in 2017 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2018 and 2021: Change in Acquisitions & Divestments tumbled 350.98% in 2018, then jumped 8063.27% in 2021.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at -$92.9 million in 2017, then jumped by 347.95% to $230.3 million in 2018, then plunged by 61.61% to $88.4 million in 2019, then sank by 32.12% to $60.0 million in 2020, then sank by 66.67% to $20.0 million in 2021.
• Business Quant data shows AKBA's Change in Acquisitions & Divestments at $20.0 million in Q2 2021, $20.0 million in Q1 2021, and $60.0 million in Q4 2020.